SCHEMBL17872157

SCHEMBL17872157

Cn1nc(Nc2cccc([N+](=O)[O-])c2)c2c1C(C)(C)N(C(=O)OC(C)(C)C)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KCNH2 Q12809 1/20 0.41
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CCNA1 P78396 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.39
LMNA P02545 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
BRD4 O60885 1/20 0.38
NSD2 O96028 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
MKNK1 Q9BUB5 3/20 0.37
C5AR1 P21730 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17872111 0.87 KMT2A (0.40) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872158 0.86 KMT2A (0.43) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872163 0.82 NTRK1 (0.47) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872084 0.80 KIF11 (0.37) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL29574061 0.80 CDK7 (0.46) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872086 0.77 MAPT (0.40) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872165 0.74 C5AR1 (0.38) MKNK1C5AR1
SCHEMBL17872129 0.74 KMT2A (0.43) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17872102 0.74 KMT2A (0.44) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL23260770 0.72 C5AR1 (0.36) SMN1; SMN2BRD4MKNK1C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3236959-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Dana Farber Cancer Institute, Inc. (US) 2017-11-01 EP disclosed
WO-2016105528-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 WO disclosed